lynn malec (@malecly) 's Twitter Profile
lynn malec

@malecly

pediatric/adult hematologist with hemophilia focus, passionate to improve care for women/girls with bleeding disorders, clinical researcher, proud cheesehead

ID: 263009109

calendar_today09-03-2011 05:29:41

132 Tweet

482 Followers

361 Following

Karin Hoffmeister (@translglycomics) 's Twitter Profile Photo

Versiti⁩ Gala Awards Dinner - Bob Montgomery won the Greenwald award !!! Congratulations Bob! 🎈🎈🎈🎈thanks to Chris Miskel our CEO ⁦@BloodResearchWI⁩

⁦<a href="/Versiti/">Versiti</a>⁩ Gala Awards Dinner - Bob Montgomery won the Greenwald award !!! Congratulations Bob! 🎈🎈🎈🎈thanks to Chris Miskel our CEO ⁦@BloodResearchWI⁩
Michael Makris (@profmakris) 's Twitter Profile Photo

In an editorial in Haemophilia Journal Hermans and Pierce discuss the recent advances in #hemophilia treatments and look forward to the time when affected individuals can lead a life with no hinderance from the disease. tinyurl.com/yc8b7bby

In an editorial in <a href="/haemophilia_jnl/">Haemophilia Journal</a> Hermans and Pierce discuss the recent advances in #hemophilia treatments and look forward to the time when affected individuals can lead a life with no hinderance from the disease. tinyurl.com/yc8b7bby
lynn malec (@malecly) 's Twitter Profile Photo

Gene therapy for hemophilia A has arrived in the US. U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe Hemophilia A prnewswire.com/news-releases/…

Andy Nowalk (@idbugdoc) 's Twitter Profile Photo

A pediatric legend and the heart and soul of CHP Pediatrics Residency . Dena taught us every day by example and with sage advice that led to a generation of Pittsburgh Pediatricians. She will be missed.

lynn malec (@malecly) 's Twitter Profile Photo

Interested in a Hematology position at Versiti? My biased opinion is our team is phenomenal 😉 Associate Medical Director/Medical Director, Versiti Medical Sciences Institute/CCBD- Adult and/or Med/Peds Hematologist (#Milwaukee, Wisconsin) #job social.icims.com/viewjob/pt1719…

Versiti Blood Research Institute (@versitiresearch) 's Twitter Profile Photo

Check out publication by VBRI Senior investigator Qizhen Shi Qizhen Shi and collaborators Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia… pubmed.ncbi.nlm.nih.gov/39067397/

Michael Makris (@profmakris) 's Twitter Profile Photo

It is time for one of the most famous slides in #hemophilia to be updated. Paper in JTH describes prospectively collected bleeding rate data in 825 children with mild hemophilia. tinyurl.com/yt4vvnes

It is time for one of the most famous slides in #hemophilia to be updated. Paper in <a href="/JTHjournal/">JTH</a> describes prospectively collected bleeding rate data in 825 children with mild hemophilia. tinyurl.com/yt4vvnes
Patrick James Lynch (@pjlynch) 's Twitter Profile Photo

If experts like Dr. Lynn Malec are still learning about #jointhealth and #hemophilia, think about how much there is still to learn, and account for, for most patients.

lynn malec (@malecly) 's Twitter Profile Photo

Such a great experience to partner with Patrick James Lynch on this episode 🎙️ ALWAYS more to learn! Staying curious drives improvements for patients 👏🏼

lynn malec (@malecly) 's Twitter Profile Photo

Montgomery Educational Symposium on Hemostasis (MESH) was a huge success thanks to the incredibly bright minds and warm hearts that gathered to honor ‘Montgomery, Milwaukee’s’ amazing career Versiti Blood Research Institute

Montgomery Educational Symposium on Hemostasis (MESH) was a huge success thanks to the incredibly bright minds and warm hearts that gathered to honor ‘Montgomery, Milwaukee’s’ amazing career <a href="/VersitiResearch/">Versiti Blood Research Institute</a>
EAHAD (@eahadnews) 's Twitter Profile Photo

Lynn Malec presents the latest from the XTEND-ed Phase 3 study! The second interim analysis reveals two-year clinical outcomes of once-weekly efanesoctocog alfa #prophylaxis in children with severe #haemophilia A. How does it impact bleed control and quality of life? #EAHAD2025

Lynn Malec presents the latest from the XTEND-ed Phase 3 study! The second interim analysis reveals two-year clinical outcomes of once-weekly efanesoctocog alfa #prophylaxis in children with severe #haemophilia A. How does it impact bleed control and quality of life? #EAHAD2025